Cargando…
Comment on: Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Associação Brasileira de Hematologia e
Hemoterapia
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672113/ https://www.ncbi.nlm.nih.gov/pubmed/23741181 http://dx.doi.org/10.5581/1516-8484.20130024 |
| _version_ | 1782272074142711808 |
|---|---|
| author | Simpson, David C |
| author_facet | Simpson, David C |
| author_sort | Simpson, David C |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3672113 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Associação Brasileira de Hematologia e
Hemoterapia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36721132013-06-05 Comment on: Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance Simpson, David C Rev Bras Hematol Hemoter Scientific Comments Associação Brasileira de Hematologia e Hemoterapia 2013 /pmc/articles/PMC3672113/ /pubmed/23741181 http://dx.doi.org/10.5581/1516-8484.20130024 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Scientific Comments Simpson, David C Comment on: Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance |
| title | Comment on: Determination of serum levels of imatinib mesylate in
patients with chronic myeloid leukemia: validation and application of a new
analytical method to monitor treatment compliance |
| title_full | Comment on: Determination of serum levels of imatinib mesylate in
patients with chronic myeloid leukemia: validation and application of a new
analytical method to monitor treatment compliance |
| title_fullStr | Comment on: Determination of serum levels of imatinib mesylate in
patients with chronic myeloid leukemia: validation and application of a new
analytical method to monitor treatment compliance |
| title_full_unstemmed | Comment on: Determination of serum levels of imatinib mesylate in
patients with chronic myeloid leukemia: validation and application of a new
analytical method to monitor treatment compliance |
| title_short | Comment on: Determination of serum levels of imatinib mesylate in
patients with chronic myeloid leukemia: validation and application of a new
analytical method to monitor treatment compliance |
| title_sort | comment on: determination of serum levels of imatinib mesylate in
patients with chronic myeloid leukemia: validation and application of a new
analytical method to monitor treatment compliance |
| topic | Scientific Comments |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672113/ https://www.ncbi.nlm.nih.gov/pubmed/23741181 http://dx.doi.org/10.5581/1516-8484.20130024 |
| work_keys_str_mv | AT simpsondavidc commentondeterminationofserumlevelsofimatinibmesylateinpatientswithchronicmyeloidleukemiavalidationandapplicationofanewanalyticalmethodtomonitortreatmentcompliance |